Skip to main content
Year archive

Hansa Biopharma — 2017 filings

All 53 regulatory filings released by Hansa Biopharma (HNSA) in 2017, sourced directly from the official regulator.

53 Filings
2017 Period
2017 filings (53)
Filing Released Lang
Major Shareholding Notification 2017
Major Shareholding Notification
2017-12-29 English
Ökning av antalet aktier och röster i Hansa Medical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-12-29 Swedish
Increase of number of shares and votes in Hansa Medical AB (publ)
Share Issue/Capital Change
2017-12-29 English
Bulletin from the extraordinary general meeting of Hansa Medical AB (publ)
AGM Information
2017-12-22 English
Kommuniké från extra bolagsstämma i Hansa MedicalAB (publ)
AGM Information
2017-12-22 Swedish
Kallelse till extra bolagsstämma i Hansa Medical AB (publ)
AGM Information
2017-11-30 Swedish
Notice of Extraordinary General Meeting of Hansa Medical AB (publ)
AGM Information
2017-11-30 English
Hansa Medicals styrelse har beslutat att genomföra en riktad nyemission om 545 MSEK
Capital/Financing Update
2017-11-29 Swedish
Hansa Medical’s Board of Directors has resolved on a directed share issue of SEK 545 million
Share Issue/Capital Change
2017-11-29 English
Hansa Medical's Nomination Committee for the AGM 2018 appointed
Report Publication Announcement
2017-11-17 English
Hansa Medicals valberedninginför årsstämman 2018 utsedd
AGM Information
2017-11-17 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-14 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-14 English
Hansa Medical announces sudden death of CEO Göran Arvidson
Board/Management Information
2017-11-08 English
Hansa Medicals VD Göran Arvidson har hastigt avlidit
Board/Management Information
2017-11-08 Swedish
Hansa Medical’s Capital Market Days provide an update on number of patients included in the company’s kidney transplantation and anti-GBM studies
Regulatory Filings
2017-10-03 English
Hansa Medical uppdaterar antalet patienter som inkluderats i bolagets kliniska studier för njurtransplantation och anti-GBM
Report Publication Announcement
2017-10-03 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification
2017-08-09 English
The New England Journal of Medicine publishes results from Phase II studies of Hansa Medical’s lead candidate IdeS in highly sensitized patients
Regulatory Filings
2017-08-02 English
The New England Journal of Medicine publicerar resultat från fas II-studier med IdeS i högsensitiserade patienter
Regulatory Filings
2017-08-02 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q2 2017
2017-07-20 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-07-20 English
First patient treated in Phase II study with IdeS in anti-GBM antibody disease
Legal Proceedings Report
2017-06-20 English
Första patienten behandlad i fas II-studie med IdeS i anti-GBM-sjukdom
Regulatory Filings
2017-06-20 Swedish
Hansa Medical presenterar vid Jefferies 2017 Global Healthcare Conference
Report Publication Announcement
2017-06-07 Swedish
Hansa Medical to present at Jefferies 2017 Global Healthcare Conference
Report Publication Announcement
2017-06-07 English
Ökning av antalet aktier och röster i Hansa Medical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-05-31 Swedish
Increase of number of shares and votes in Hansa Medical AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-05-31 English
Kommuniké från årsstämma i Hansa Medical AB (publ)
AGM Information
2017-05-24 Swedish
Resolutions adopted at the annual general meeting of Hansa Medical AB (publ)
AGM Information
2017-05-24 English
Published preclinical results confirm IdeS potential in cancer immunotherapy
Regulatory Filings
2017-05-23 English
Publicerade prekliniska resultat bekräftar IdeS potential inom cancerimmunterapi
Regulatory Filings
2017-05-23 Swedish
IdeS har beviljats tillgång till EMAs process för prioriterade läkemedel; PRIME
Regulatory Filings
2017-05-19 Swedish
IdeS selected for EMA Priority Medicines (PRIME) scheme
Regulatory Filings
2017-05-19 English
Emission och återköp av C-aktier för incitamentsprogram
Share Issue/Capital Change
2017-04-27 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-26 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-04-26 English
Annual Report 2016
Annual Report FY 2016
2017-04-26 Swedish
Annual Report 2016
Annual Report FY 2016
2017-04-26 English
Kallelse till årsstämma i Hansa Medical AB (publ)
AGM Information
2017-04-24 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN Hansa Medical AB (publ)
AGM Information
2017-04-24 English
Hansa Medical bjuder in till webbsänd telefonpresentation av bolagets delårsrapport för första kvartalet 2017
Report Publication Announcement
2017-04-19 Swedish
Hansa Medical to Host Conference Call to Provide First Quarter 2017 Business Update
Report Publication Announcement
2017-04-19 English
Hansa Medical utser Sam Agus till ny Chief Medical Officer
Board/Management Information
2017-03-31 Swedish
Hansa Medical appoints Sam Agus as new Chief Medical Officer
Board/Management Information
2017-03-31 English
Presentation av resultat från den amerikanska studien med IdeS vid American Transplant Congress
Investor Presentation
2017-03-29 Swedish
Top-line clinical results from US study with lead candidate IdeS to be presented at the American Transplant Congress
Regulatory Filings
2017-03-29 English
Hansa Medical presenterar vid The Oppenheimer 27th Annual Healthcare Conference
Regulatory Filings
2017-03-08 Swedish
Hansa Medical to present at The Oppenheimer 27th Annual Healthcare Conference
Regulatory Filings
2017-03-08 English
Novel pre-clinical in vivo data demonstrate the treatment potential of IdeS in Guillain-Barré syndrome (GBS)
Regulatory Filings
2017-02-16 English
Nya prekliniska in vivo-data visar potentialen för IdeS behandling i Guillain-Barrés syndrom (GBS)
Regulatory Filings
2017-02-16 Swedish
Audit Report / Information 2016
Audit Report / Information FY 2016
2017-02-15 Swedish
Interim / Quarterly Report 2016
Interim / Quarterly Report Q4 2016
2017-02-15 English